Employees: 11 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2005-11-29 (20 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PERPIGNAN (66100), Pyrenees-Orientales
PHARMACIE ADIN : revenue, balance sheet and financial ratios
PHARMACIE ADIN is a French company
founded 20 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PERPIGNAN (66100),
this company of category PME
shows in 2021 a revenue of 3.0 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE ADIN (SIREN 487472243)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
3 017 183 €
2 809 028 €
2 575 702 €
2 464 532 €
2 382 883 €
2 255 043 €
Net income
163 970 €
20 539 €
55 195 €
481 965 €
299 314 €
193 773 €
198 413 €
160 986 €
158 305 €
155 683 €
EBITDA
N/C
N/C
N/C
N/C
400 233 €
271 238 €
262 683 €
224 351 €
243 274 €
241 551 €
Net margin
N/C
N/C
N/C
N/C
9.9%
6.9%
7.7%
6.5%
6.6%
6.9%
Revenue and income statement
In 2025, PHARMACIE ADIN generates positive net income of 164 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 156 k€ -> 164 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
163 970 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 53%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 50%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
52.634%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
50.158%
Solvency indicators evolution PHARMACIE ADIN
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
400.347
258.985
181.513
128.039
96.808
68.887
45.366
36.254
61.192
52.634
Financial autonomy
16.354
23.071
29.878
37.659
42.726
48.768
56.647
60.531
50.445
50.158
Repayment capacity
9.59
8.57
9.186
5.643
5.028
3.008
None
None
None
None
Cash flow / Revenue
6.879%
6.72%
5.539%
7.798%
7.424%
10.492%
None%
None%
None%
None%
Sector positioning
Debt ratio
52.632025
2023
2024
2025
Q1: 13.57
Med: 49.47
Q3: 128.28
Average+17 pts over 3 years
In 2025, the debt ratio of PHARMACIE ADIN (52.63) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
50.16%2025
2023
2024
2025
Q1: 33.69%
Med: 53.88%
Q3: 72.26%
Average-20 pts over 3 years
In 2025, the financial autonomy of PHARMACIE ADIN (50.2%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE ADIN
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
372 217 €
413 716 €
482 531 €
507 594 €
602 845 €
677 810 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
44
41
39
39
43
46
0
0
0
0
Customer payment term (days)
7
5
6
7
5
6
0
0
0
0
Supplier payment term (days)
55
54
53
48
50
54
0
0
0
0
Positioning of PHARMACIE ADIN in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE ADIN is estimated at
2 604 682 €
(range 1 767 550€ - 4 087 106€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1767k€2604k€4087k€
2 604 682 €Range: 1 767 550€ - 4 087 106€
NAF 5 année 2025
Valuation method used
Net Income Multiple
163 970 €
×
15.9x
=2 604 683 €
Range: 1 767 550€ - 4 087 106€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE ADIN with other companies in the same sector:
Yes, PHARMACIE ADIN generated a net profit of 164 k€ in 2025.
Where is the headquarters of PHARMACIE ADIN ?
The headquarters of PHARMACIE ADIN is located in PERPIGNAN (66100), in the department Pyrenees-Orientales.
Where to find the tax return of PHARMACIE ADIN ?
The tax return of PHARMACIE ADIN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE ADIN operate?
PHARMACIE ADIN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart